Your session is about to expire
← Back to Search
Stem Cell Regeneration for Gum Recession
N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Presence of periodontally healthy teeth at the recipient site
No previous harvesting procedure involving the palate
Must not have
Presence of periodontal disease at the recipient site
Patients that have severe gingival recession (Miller class III and IV) or < 2 mm
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at day 1 visit 1
Awards & highlights
No Placebo-Only Group
Summary
This trial uses special cells from the gums that can turn into different types of tissues. It targets patients undergoing gum grafting surgery. These cells help repair and regenerate damaged tissues by transforming into the needed cell types.
Who is the study for?
This trial is for English-speaking patients at the UAB Dental School with healthy teeth and gums who need a soft tissue graft due to mild to moderate gum recession. They must be able to maintain good oral hygiene, not be pregnant or breastfeeding, and not have had previous palate surgery.
What is being tested?
The study aims to compare the regenerative abilities of mesenchymal stem cells taken from two areas in the mouth's roof (palate) - near the front (premolar) and back (molar). It will help optimize how these cells are used in repairing tissues like bone and gums.
What are the potential side effects?
Since this trial involves harvesting cells rather than drug treatment, side effects may include discomfort or pain at the extraction site, bleeding, infection risk, swelling, and possible complications related to wound healing.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My gums and teeth are healthy where I need treatment.
Select...
I have never had tissue taken from the roof of my mouth.
Select...
I need a gum graft for my teeth with mild to moderate recession.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have gum disease where I will receive treatment.
Select...
I have severe gum recession.
Select...
I am taking medication that can cause gum swelling.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at day 1 visit 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at day 1 visit 1
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Osteogenic potential
Secondary study objectives
Adipogenic potential
Genotype assay
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Progenitor Potential at Premolar siteExperimental Treatment1 Intervention
Harvested tissue from the front (premolar) part of the palate will be used to extract the gingival mesenchymal cells to test their progenitor potential to differentiate into multiple cell lineage.
Group II: Progenitor Potential at Molar siteExperimental Treatment1 Intervention
Harvested tissue from the back (molar) part of the palate will be used to extract the gingival mesenchymal cells to test their progenitor potential to differentiate into multiple cell lineage.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for gum recession include connective tissue grafts, laterally positioned flaps, and tunneling techniques. These methods primarily work by covering the exposed root surfaces and promoting the regeneration of gum tissue.
Connective tissue grafts involve taking tissue from another part of the mouth and attaching it to the affected area, which helps in thickening the gum and covering the recession. Laterally positioned flaps and tunneling techniques involve repositioning existing gum tissue to cover the exposed roots.
The use of mesenchymal stem cells (MSCs) in these treatments is being studied for their regenerative and differentiation potential, which could enhance tissue repair and regeneration. This matters for patients as MSCs could potentially offer more effective and long-lasting solutions for gum tissue regeneration, reducing the need for more invasive procedures.
Root Coverage Predictability in the Treatment of Gingival Recessions on Mandibular Anterior Teeth.
Root Coverage Predictability in the Treatment of Gingival Recessions on Mandibular Anterior Teeth.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,646 Previous Clinical Trials
2,342,763 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have any health conditions that would interfere with surgery or healing.I have gum disease where I will receive treatment.I have not had a palate harvesting procedure in the last year.I am not on any medications that cause gum swelling.I have severe gum recession.I have poor oral hygiene.My gums and teeth are healthy where I need treatment.My teeth at the treatment area are healthy.I have never had tissue taken from the roof of my mouth.I need a gum graft for my teeth with mild to moderate recession.I am taking medication that can cause gum swelling.
Research Study Groups:
This trial has the following groups:- Group 1: Progenitor Potential at Molar site
- Group 2: Progenitor Potential at Premolar site
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger